Editor(s):
(1) Dr. Rafik Karaman, Professor, Al-Quds University, Palestine.
Reviewers:
(1) Farnaz Sadat Fattahi, Isfahan University of Technology, Iran.
(2) Ved Srivastava, Aktis Oncology, USA.
(3) Suresh Kumar Karri, Bioplus Life Sciences Private Limited, Pharmed Gardens, India.
Additional Reviewers:
(1) Deng-Guang Yu, University of Shanghai for Science and Technology, China.
(2) Dhruba Sankar Goswami, Gitanjali College of Pharmacy, India.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 5.33/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Farnaz Sadat Fattahi, Iran) | File 1 | File 2
Stage 2 | Peer review report_2 (Ved Srivastava, USA) | File 1 | File 2
Stage 2 | Peer review report_3 (Suresh Kumar Karri, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA